17/09/2025
The Transform Trial is a multi-million pound project designed to change how aggressive prostate cancer is detected at the earliest stage – a goal we all share. About the Trial Recruitment will be GP-led, starting with 10,000–12,000 men over 2–3 years, with the aim of expanding to 200,000–300,000 men nationwide. Participants will be split into two groups: Testing group: A mix of approaches, including PSA alone, PSA with MR...
Read More
15/09/2025
How do you look after the health of your workforce?At GFCT, we run workplace health testing events that make it easy for employees to take control of their health.For male-dominated industries (police, construction, transport, manufacturing), we provide PSA testing – a simple blood test that can help detect prostate cancer early, when it’s most treatable.For mixed teams, we also offer general health tests including cholesterol and diabetes checks – helping staff catch potential...
Read More
10/09/2025
From our founder, Graham: "Monday 8th September was an interesting day in the journey of the charity. Firstly, a very positive article in the Daily Telegraph about the efforts the charity is making to increase the awareness of prostate cancer. Followed by Sue, my beloved and long suffering wife, and I not only completing the last leg of the 630 mile South West Coast Path walk but also celebrating our 52nd wedding anniversary. It's not often that 3 such important events ha...
Read More
07/09/2025
What if a simple blood test today could save your life tomorrow? Find out how… Through conducting over 16,000 health tests, our results show that around 39% of adults score outside normal ranges on their health tests. Our Testing Events With help from partner organisations, we organise health testing events all over the UK for the public to attend. Simply register online, book your slot and turn up for a quick blood test. What can you get a test for? Your blo...
Read More
03/09/2025
A recent report has revealed that thousands of men with prostate cancer in England are being denied access to abiraterone, a low-cost drug that could save hundreds of lives each year. What is Abiraterone? Blocks the production of testosterone, which fuels prostate cancer growth. Already available on the NHS for men with advanced, incurable cancer. A 2022 clinical trial proved it is also effective for men with high-risk cancer that has not...
Read More
29/08/2025
Today’s Telegraph article featured GFCT and our mission to make PSA testing more accessible for men across the UK. If you’re new to hearing about our work, please have a read of this summary to learn about what we do and how it might save your life. Testing in the Community At our recent event in Warwick’s Nelson Club, nearly 200 men attended for a simple PSA blood test. These events (hosted in community spaces like clubs, churches, and sports...
Read More
27/08/2025
Did you know that a raised PSA doesn’t always mean cancer? It could point to an enlarged prostate - a common condition with effective treatments available. One treatment option that we would like to particularly highlight is Aquablation therapy. Who is it for? Whilst it is understood, Aquablation is NOT currently a suitable treatment for prostate cancer. It is further understood that there are some ongoing clinical trials to determine if it could help in certain circumstances.&nb...
Read More
24/08/2025
Recent press coverage has highlighted the success of our ongoing prostate cancer screening programme, promoted by Stratford District Council. So far, 636 tests have been carried out across Stratford, Studley, Southam and Alcester. Of these, 373 men took part in prostate cancer testing. Results have already proved vital, with 83 men referred for further tests via their GP. Alongside prostate cancer screening, tests for diabetes and cholesterol&nbs...
Read More
22/08/2025
Thanks to the support of Vista Health, part of the InHealth Group, we are delighted to offer hospitals the use of a mobile MRI Scanning Unit at the current NHS tariffs of £147 for a reported non contrast scan and £212 for a reported contrast scan. This incredibly attractive offer is based on a consecutive minimum two, but preferably four-day visit by the scanning unit on hospital premises. The target will be twenty scans a day, thereby helping reduce backlogs and bottlenecks. Th...
Read More
20/08/2025
We're delighted to announce a new collaboration with Vista Health, one of the country's leading scanning providers with over 50 sites in the UK. Why a prostate MRI? Provides a highly detailed view of your prostate MRI scans can reveal signs of prostate cancer, even before changes appear in PSA levels Is a non-invasive, quick, and pain-free procedure GFCT Treatment Support are subsidising MRI scans making them a more accessible option, improving vital insights ...
Read More